Follow the Mendus AB (publ) share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Mendus AB (publ) has recorded 1 public disclosures. Market capitalisation: €345.6m. The latest transaction was filed on 13 March 2025 (Purchase). Among the most active insiders: Erik Manting. The full history is openly available.
Analysts rate Mendus AB (publ) Buy (bullish), based on 1 analysts. Average price target: SEK 16.00.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration